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Micropollutants (MPs) are recalcitrant chemicals (i.e., 
pharmaceuticals, illicit drugs, hormones and personal care 
products) that are found in wastewater effluent at ng/L to µg/L 
concentration range.
Moving Bed Biofilm Reactors (MBBRs) have been recently 
proposed as a valid alternative to conventional activated sludge 
(CAS) to enhance the elimination of pharmaceuticals during 
biological wastewater treatment (Escolà Casas et al., 2015; Falås 
et al., 2016, 2012; Hapeshi et al., 2013; Torresi et al., 2016).
 » Pre-denitrifying MBBR (MBBR 1): how MBBR staging and 
tiered substrate availability influences denitrification and 
removal of MPs
 » Nitrifying MBBR (MBBR 2): how biofilm thickness influences 
nitrification and removal of MPs
 » Post-denitrifying MBBR (MBBR 3): how external carbon source 
(methanol and ethanol) influences denitrification and removal 
of MPs
Three different operations  
of MBBR
MBBR for removal of 
micropollutants 
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WATER TECHNOLOGIES
How can 
we operate 
strategically 
MBBRs to enhance 
removal of 
micropollutants?
MBBR 1
MBBR 2 MBBR 3
Two pre-denitrifying MBBR 
configurations, with single-stage 
(U) and three-stage (S1, S2, S3) 
bioreactors were operated in parallel 
for 1.5 years. Due to staging, S1, S2 
and S3 were exposed to a decreasing 
trend of organic carbon degradability.
MBBR 1: Pre-denitrification 
AnoxKaldnes Z-carriers with 
grids of defined heights were 
used to control maximum biofilm 
thickness.
Two nitrifying reactors with 
Z-carriers of biofilm thickness 
ranging from 50 µm (Z50) to 500 
(Z500) were operated in parallel for 
approximately 200 days.
The nitrification rate (rNH4_B) was 
found significantly higher for 
Z50 MBBR compared to the other 
Z-carriers. kbio were positively 
correlated with biofilm thickness 
for 14 out of 22 compounds, not 
correlated for four compounds, 
negatively correlated for three 
sulfonamide antibiotics and 
diclofenac (DCF).
Thin biofilm (~50 µm) could  achieve complete nitrification and 
increase the removal of some key compounds (sulfonamides and 
diclofenac) 
Biofilm technologies based on thicker biofilms could enhance the 
removal of a major number of micropollutants. 
Biofilm thickness influences biodiversity in nitrifying MBBRs – Implications on 
micropollutant removal. Environmental Science & Technology (2016), 50, 9279-
9288.
MBBR 2: Nitrification
Batch experiment showed that 
several compounds (i.e atenolol, 
sulfamethoxazole, trimethoprim) 
were effectively removed in anoxic 
MBBRs with biotransformation rate 
constants kbio (as well as denitrification 
rate) enhanced in S1.
Positively correlation was found between MP biotransformation  
rate constants and denitrification rates, possibly indicating  
co-metabolism of MPs in the 4 pre-denitrifying MBBRs.
Removal of pharmaceuticals in pre-denitrifying MBBR—Influence of organic 
substrate availability in single- and three-stage configuration.  
Water Research  (2017), 123, 408,419
Two laboratory-scale MBBRs, 
containing AnoxKaldnes K1 
carriers with acclimated biofilm 
from full-scale systems, were 
operated in continuous-flow using 
wastewater dosed with methanol 
and ethanol.
The methanol-dosed MBBR 
showed higher (e.g., 1.5 to 2.5-
fold) or comparable kbio to the 
ethanol-dosed MBBR for 15 out of 
22 targeted compounds. 
Conversely, denitrification was 
enhanced in the MBBR dosed with 
ethanol.
During continuous-flow operation 
at conditions representative of 
full-scale systems (hydraulic residence time = 2 h), the removal 
efficiencies of micropollutants were below 35% in both MBBRs, with 
the exception of atenolol and trimethoprim (>80%)
Impact of external carbon dose on the removal of micropollutants using 
methanol and ethanol in post-denitrifying Moving Bed Biofilm Reactors.  
Water Research (2017), 108, 95-105
MBBR 3: Post-denitrification
The three MBBR systems 
presented improved 
kbio as compared to 
CAS for atenolol (in 
figure) and for a number 
of pharmaceuticals 
(e.g., diclofenac, 
sulfamethoxazole, 
erythromycin) 
 » The post-denitrifying 
MBBR 3, that was 
supplemented with more readily degradable carbon sources 
(ethanol, methanol) compared to MBBR 1, exhibited the highest 
kbio. 
 » The availability of primary substrates (carbon and nitrogen) 
was found crucial for the biotransformation of pharmaceuticals in 
the three MBBR systems, suggesting removal via cometabolism. 
 » Overall, our results suggest that MBBR can be a valuable 
alternative to CAS in enhancing the removal of several 
micropollutants both under aerobic and anoxic conditions.
Comparison with CAS
